CS

Commercial Street Capital

North America, Texas, United States, Dallas

Description

Commerce Street Capital is a Member FINRA/SIPC and an investment banking firm serving financial institutions and middle-market companies.

Investor Profile

Commercial Street Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Medical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Commercial Street Capital frequently co-invest with?

Soros Fund Management
North America, New York, United States, New York
Co-Investments: 1
AC
North America, New York, United States, New York
Co-Investments: 2
BF
North America, Texas, United States, Fort Worth
Co-Investments: 2
OPKO Health
North America, Florida, United States, Miami
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2

Which angels does Commercial Street Capital often collaborate with?

AB
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Commercial Street Capital?

Arno Therapeutics

Parsippany, New Jersey, United States

Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.

BiopharmaBiotechnologyMedical
Post Ipo EquityAug 16, 2016
Amount Raised: $8,000,000
Arno Therapeutics

Parsippany, New Jersey, United States

Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.

BiopharmaBiotechnologyMedical
Post Ipo EquityJan 13, 2016
Amount Raised: $7,400,000

Find More Investors Like Commercial Street Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Commercial Street Capital | Pipeseed